Karpas-384Homo sapiens (Human)Cancer cell line

Also known as: KARPAS384, KARPAS 384, Karpas 384

🤖 AI SummaryBased on 1 publications

Quick Overview

T-cell line with CDKN2 deletions for cancer research.

Detailed Summary

Karpas-384 is a T-cell line derived from a patient with leukemic transformation of T-cell non-Hodgkin's lymphoma (T-NHL). This cell line exhibits biallelic deletions of the CDKN2 gene, which is implicated in the pathogenesis of various lymphoid malignancies. The CDKN2 gene, located on chromosome 9p21, functions as a tumor suppressor by regulating the cell cycle. Biallelic deletions of CDKN2 have been associated with the transformation of low-grade NHL to high-grade disease and with increased proliferation in SCID mice. Karpas-384 is used in research to study the role of CDKN2 in lymphoid malignancies and the mechanisms of tumor progression. The cell line was derived by Dr. A. Karpas and is part of a panel of lymphoid cell lines analyzed for CDKN2 abnormalities.

Research Applications

Study of CDKN2 gene deletions in lymphoid malignanciesInvestigation of tumor suppressor gene function in T-cell lymphomasAnalysis of lymphoma transformation mechanisms

Key Characteristics

Biallelic CDKN2 deletionsT-cell lineageLeukemic transformation of T-NHL
Generated on 6/19/2025

Basic Information

Database IDCVCL_2541
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age48
Age CategoryAdult
SexMale

Disease Information

DiseasePrimary cutaneous T-cell lymphoma
LineageLymphoid
SubtypeAdult T-Cell Leukemia/Lymphoma
OncoTree CodeATLL

DepMap Information

Source TypeAcademic lab
Source IDACH-001097_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gln61Lys (c.181C>A)UnspecifiedAcquired during resistance selection processPubMed=26214590
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

A new human T-cell lymphoma cell line (Karpas 384) of the T-cell receptor gamma/delta lineage with translocation t(7:14) (p13;q11.2).

Karpas A.

Leukemia 7:1047-1053(1993).

Deletions and rearrangement of CDKN2 in lymphoid malignancy.";

Millar J.L., Catovsky D., Dyer M.J.S.

Blood 85:893-901(1995).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).